ETS1’s influence on CDKN1B implicates it in cell cycle regulation and potentially in the control of hepatocyte proliferation and apoptosis, processes central to NASH progression and liver regeneration. Here, CDKN1B is linked to metabolic dysfunction-associated steatohepatitis.